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SUMMARY
Age-specific patterns of rotavirus infection were investigated using a randomly selected and
representative sample of sera from a suburban community of Sa4 o Paulo, Brazil screened for
class-specific antibodies to group A rotavirus. Age-serology of anti-rotavirus IgG showed
primary infection predominant in young infants with a median age of around 18 months
consistent with IgM serology suggesting highest rates of recent infection between ages 4 and 48
months. Anti-rotavirus serum IgA prevalence increased gradually with age. Paired samples
from infants, collected 1 month apart, indicated high exposure rates with seroconversion
occurring in several infants during the reported low transmission season. Between 5 and 10%
of adults had elevated IgM levels indicative of recent infection and, potentially, of an
important contribution adults may play to rotavirus transmission. Further understanding of the
dynamics of rotavirus transmission within populations, at group and serotype level, would
benefit the design and monitoring of future immunization programmes.
INTRODUCTION
Worldwide, rotaviral gastroenteritis is responsible for
upwards of 1 million deaths and considerable mor-
bidity each year in children under the age of 5 years
[1]. The extent of rotavirus infection and associated
disease amongst older age groups is less well docu-
mented due to milder clinical outcome [2] and thus
reduced likelihood for case reporting. Mild disease in
infants may also go largely unreported leading to a
vast underestimate of the extent of infection and,
therefore, of levels of rotavirus transmission within
communities. In the UK, for example, a large
proportion of rotaviral infection will be treated by
community physicians [3].
* Author for correspondence.
Rotaviruses are genetically diverse pathogens. Al-
though many of the 14 VP7 based serotypes have been
isolated from humans, four have been shown to be
responsible for the majority of clinical disease to date
[4]. Licensing of a live oral tetravalent rotavirus
vaccine (containing the four common serotypes) is
expected in the USA and Europe before the end of
1998 and will be considered as part of the WHO EPI
programme [5]. The vaccine is partially effective
against severe diarrhoea but apparently does not
prevent viral shedding and, therefore, virus trans-
mission. The effects of community-based use of such
a vaccine on patterns of infection and disease are
largely unknown. In part, this is because of insufficient
understanding of the relationship between within host
infection dynamics and population level patterns of
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immunity and transmission. A better understanding
of patterns of transmission, prior to immunization, is
required so that optimal immunization programmes
can be designed and possible effects on the stability of
disease patterns can be predicted.
Detailed cross-sectional seroepidemiological data
has proved useful in the past in linking within host
patterns of infection with those at the population level
[6], including the potential impact of mass vaccination.
In particular, this has involved the use of math-
ematical models of infection transmission [6]. Such
methodology applied to rotaviruses would have to be
more complex to incorporate the existence of multiple
strains and their possible interactions [7] as well as the
possible role of animal reservoirs in rural populations.
These aims would be a longer term goal of sero-
epidemiological and theoretical studies. However,
basic epidemiological patterns of group A rotavirus
remain to be investigated.
Primary infection with rotavirus in infants can
occur very rapidly after birth, sometimes within the
first few days [8]. Most infants have evidence of
infection by 3 years of age as recorded in sero-
epidemiological studies from several countries [9–13].
However, studies to investigate dynamics of infection,
including information on class-specific antibodies,
across a broad age range and which are representative
of normal populations are few [14]. Most studies of
rotavirus epidemiology have concentrated on clinical
and, less frequently, on sub-clinical, disease in infants,
using (self)-selected samples (e.g. hospital admissions
or outpatients) and have largely ignored patterns of
infection in older age groups. There is a clear need for
well-designed community studies of rotavirus based
infection on fully age-stratified samples representative
of the study population.
A serum survey conducted in Sa4 o Paulo in the
summer of 1990 [15] has provided the opportunity to
investigate patterns of serological markers of rotavirus
infection representative of a study population. We
report age-specific and class-specific antibody titres to
group A rotavirus and the results are interpreted with
respect to patterns of viral transmission.
METHODS
Demographic details and methods used in sampling
the community have been described in detail pre-
viously [15]. The study took place in December and
January 1991. Blood samples for serum were collected
from the town of Caieiras, in northern Sa4 o Paulo,
chosen as representative of a suburban Brazilian
community. Standard theory [16] was applied to
achieve a random 2-level cluster sample from families
within randomly selected administrative regions.
Informed consent was obtained from parents or
guardians. Thirty-nine pairs of maternal-cord sera
were also collected from Caieiras Regional Hospital.
The age-structure of the samples used in this study are
presented in Table 1. A repeat blood sample was
collected from children under 2 years of age after a
period of exactly 1 month. Serum separated from
blood samples was stored at ®20 °C. Aliquots were
prediluted 1:20 in 1:1 phosphate-buffered saline
(PBS)}glycerol to preserve antibody during storage
and use.
Enzyme-linked immunosorbant assays (EIA) were
used to measure group A anti-rotaviral antibodies.
Bovine rotavirus strain UKtc was grown in BSC-1
cells and used as antigen, non-infected cells were used
as control antigen. Infected and non-infected cells
were prepared for use as antigen by freeze-thawing
and clarified by low speed centrifugation. A modified
indirect EIA was used for the detection of IgG and
IgA antibodies. Plates were coated with optimally
diluted polyclonal rabbit hyper-immune anti-rota-
virus antibody (carbonate buffer, pH 9±6, 4 °C over-
night). Antigen or control was added in excess to
plates diluted in PBS with 0±05% Tween-20 (Tw) with
2% skimmed-milk powder (SMP) at room tem-
perature (RT) for 2 h followed by washing three times
using PBS-Tw, Test sera, diluted in PBS-Tw-SMP,
were added at 1}200 to test and control plates for 2 h
RT followed by washing. Rabbit anti-human HRP
conjugate, IgG or IgA, (Dako) at 1}2000, was added
for a further 2 h RT. After final washing TMB
substrate in citrate-phosphate buffer was added for
30 min then stopped with 3 m H
#
SO
%
and read at
450 nm. Paired samples were screened in adjacent
wells on the same plate.
IgM antibodies were detected using a capture-
antibody assay with incubation, washing and devel-
oping procedures as above. Plates were coated with
optimally diluted affinity-purified goat anti-human
IgM (Sigma) at 4 °C overnight. Sera was added at
1}100 dilution. Antigen diluted in PBS-Tw-SMP was
then added in excess and was subsequently detected
using an HRP-linked monoclonal anti-group A
rotavirus antibody.
Internal standards made up from a pool of adult
sera with high titre class-specific antibody were
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Table 1. Sample sizes, by age, collected in December
1990 (initial survey), including maternal-cord pairs
and during a repeat survey (January 1991) exactly 1
month later
Age in
months (years) Initial Repeat
0 39 0
1–2 27 18
3–4 22 18
5–6 27 23
7–8 48 36
9–10 37 22
11–12 27 17
13–18 29 22
19–23 25 17
24 (2) 50 0
36 (3) 44 0
48 (4) 33 0
60 (5) 14 0
–120 (–10) 35 0
–180 (–15) 12 0
–240 (–20) 20 0
–360 (–30) 43 0
–480 (–40) 17 0
Total 549 173
included in all plates. Neat standard was given the
arbitrary concentration of 1000 units and double
diluted to 1}128 (in PBS}glycerol) to construct a
standard curve. Standards were included in each plate
against which optical densities of test sera were
compared and concentrations calculated in log
"!
units.
Levels of antibody concentrations for antibody classes
were not directly comparable. No correlations were
seen between IgG, IgM and IgA titres in cord sera
showing that the IgM and IgA assays were not
detecting non-specifically bound anti-rotaviral IgG.
Data were analysed using Quattro2 Pro7 (Corel,
1997) and SPSS v.6 (SPSS Inc. 1993).
RESULTS
Frequency distributions of antibody concentrations
for all samples for each antibody class can be seen in
Figure 1. A clear bimodal distribution for IgG
suggested a suitable cut-off for seropositivity at 1±5 log
units (Fig. 1a). For IgM and IgA negative skewed
unimodal distributions indicate considerable overlap
between individuals with low titres and seronegatives
(Fig. 1b, c). Class-specific antibody titres for all
200
(a)
150
100
50
0
0 –0·4 –0·8 –1·2 –1·4 –1·6 –2 –2·8 –3·6
Fr
eq
ue
nc
y
(b)
1·5
100
80
60
40
20
0
2·0 2·5
–0 –1·1–1·3–1·5–1·7–1·9–2·1–2·3–2·5–2·7 –2·9–3·5 –5 –7
(c)
140
80
60
40
20
0
0 –1·1 –1·3 –1·5 –1·7 –1·9 –2·25
1·8 2·25
120
100
–3 –4
Log units
Fig. 1. Frequency distributions of antibody concentrations
for total samples (n¯ 722). (a) IgG, (b) IgM and (c) IgA.
Graphs show cut-off values (log
"!
units) used for age-
serological profiles.
individuals in the initial survey (n¯ 549), regardless
of serostatus are shown in Figure 2(a, b), for IgG
and IgM respectively. Levels of IgG showed a clear
decrease over the first 6–9 months of age consistent
with decay in maternally derived antibodies. High
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Fig. 2. Scatter plots showing antibody levels (log
"!
units) for
all samples (n¯ 549). (a) IgG and (b) IgM. Note that age (x
axis) is presented on two separate linear scales ; 0–2 years
and 3–38 years.
Table 2. Summary statistics for IgG antibody levels
for seropositive individuals (designated as " 1±5 log
"!
units, see Fig. 1a) aged between 6 months and 40
years showing separate details for maternal and cord
samples
Age group
(months) No.
Mean
(log
"!
units) Variance
6–15 71 2±51 0±118
16–35 69 2±35 0±174
36–60 78 2±36 0±143
72–120 27 2±25 0±116
132–240 30 2±34 0±149
252–480 53 2±23 0±190
Maternal 39 2±07 0±214
Cord 39 2±20 0±169
titres were recorded in some individuals in the first few
months after birth suggesting recent infection. From 6
months of age two populations of individuals are
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Fig. 3. The change, with age, in the proportion seropositive
using arbitrary cut-off values (log
"!
units) based on
frequency distributions in Figure 1. (a) IgG cut-off at 1±5
(+) ; (b) IgM at 2±0 (+) and 2±5 (y) ; (c) IgA at 1±8 (+) and
2±25 (y). Samples sizes for each age class as in Table 1.
visible, those with IgG levels ! log 1±5 units (sero-
negative) and those with levels " log 1±5 units
(seropositive) indicative of experience of primary
infection. Beyond 2–3 years of age these two popu-
lations are less distinct with most individuals ap-
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pearing seropositive. Means and variance of titres in
different age groups were calculated for individuals
with titres greater than 1±5 log units (Table 2.). Linear
regression analysis revealed a marginally significant
increase in titre between 6 and 15 months of age
inclusive (n¯ 71, F¯ 3±98, P¯ 0±0499). Overall there
was a significant decline in titre through to adulthood
(age "¯ 6 months, n¯ 328, F¯ 6±74, P¯ 0±0098).
Only IgG antibodies were maternally-derived. There
was significant correlation in IgG titres between
maternal and cord sera (correlation coefficient¯
0±949) and mean titres (Table 2) in cord sera were
significantly higher (t-test for paired samples,
t¯®5±41, d.f.¯ 38, 95% CI ®0±179, ®0±082).
Age-specific trends in IgM antibody levels, Figure
2b, revealed that, whilst most individuals have low
level antibody, some of individuals have significantly
higher concentrations. Highest IgM titres were seen in
infants aged between 6 months and 2 years of age.
Nevertheless, all age groups, including adults, had
individuals with high IgM titres.
Arbitrary cut-offs were defined from frequency
distributions of antibody titres (Fig. 1) to illustrate
age-trends more clearly. The age-serological profiles
in Figure 3 give a clearer indication of age patterns of
apparent seropositivity. There was a rapid rise of IgG
prevalence, from 3 months to 5 years stabilizing
around 90–95% in adults. IgM seroprevalence
appears highest in the age range 6 months to 3 years
and IgA prevalence appears to rise throughout the age
profile. A prevalence of 0% in the 11 to 15-year-old
age group was odd but possibly an artifact of small
sample size (n¯ 12).
A comparison of IgG antibody levels in paired
samples revealed only two samples with clear increases
in antibody titre (data not shown). A greater pro-
portion showed a decrease in antibody which, when
stratified by age (Fig. 4a) could be seen mostly in
infants less than 5 months of age reflecting decay in
maternally-derived antibody. In most samples there
was little variation. There was clearly more variation
in IgM levels between the two time points (Fig. 4b).
Several samples showed a large increase in titre with
those initially high showing a decrease over the one
month period. Increases were evenly distributed across
age groups and decreases in slightly older infants
(data not shown). IgA titres (Fig. 4c) were also seen to
increase as well as decrease during the 1 month period
in a number of individuals but were less pronounced
than IgM.
Correlations between class-specific antibody titres
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Fig. 4. The change in antibody titre after 1 month in paired
samples from individuals aged between 1 and 24 months
(n¯ 173) for (a) IgG, (b) IgM, (c) IgA. Graphs show (a) the
change in titre for each monthly age group (IgG) or (b, c)
the initial titre plotted against the titre in the repeat sample
(IgM and IgA).
within individuals in the cross-sectional survey and in
paired samples were investigated but with small
sample sizes of high titre individuals no obvious
patterns emerged.
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DISCUSSION
Studies in Sa4 o Paulo, Brazil have identified rotavirus
as an important cause of morbidity [17, 18]. Trans-
mission has been reported to occur throughout the
year but to show seasonality peaking in the winter
months (July–September) [19]. The aim of this study
was to use basic seroepidemiology as a means of
increasing our understanding of infection dynamics
within this population, provide data to support future
mathematical modelling of rotavirus infection and
form a basis for more detailed serotype-specific
epidemiological studies. Samples used in this study
were not biased towards individuals who may have
gastroenteritis, or self-selected through hospital ad-
missions or outpatients although individuals who may
have had recent disease were not actively excluded.
They are, therefore, representative of the normal
population and the prevalence of any recent or current
infection or seroconversion that occurs within the
individuals due to rotavirus can be used as an
indicator of transmission within the wider community
at that time. Although transmission of rotavirus
occurs throughout the year the study was carried out
when transmission is reportedly lower. It is possible,
therefore, that different serological patterns would be
seen for a study conducted during the winter months.
However, cross-sectional age-serological profiles not
only measure age-dependent effects but time-depen-
dent processes as well [6]. Seasonality in transmission
patterns could be reflected in cross-sectional sero-
epidemiological surveys given large enough sample
sizes to enhance sensitivity.
Although cut-off points were used to differentiate
seropositive from seronegative individuals, data pre-
sented as titres from all individuals can give a more
detailed impression of the dynamics of infection
within communities. Other than for IgG no precise
distinction between seropositive and negatives could
be presumed, however arbitrary cut-offs gave indica-
tions of changes with age in the proportion of
individuals with relatively high antibody levels. We
have used IgM, shown to be short-lived after clinical
rotaviral infection [20], as a marker of current or
recent infection. The dynamics of an IgM response
upon repeated infection are not well understood and
may vary between individuals dependant on age, time
since last exposure and perhaps more importantly on
the infecting rotavirus serotype. It may be that
repeated infection with a homologous serotype in-
duces a lower or negligible IgM response. IgG
seroconversion is certainly not always associated with
an IgM response [21] suggesting that using IgM may
underestimate reinfection. Furthermore, loss of IgM
activity due to long term storage was likely to add to
an underestimate of prevalence. Age-specific preva-
lence of high IgM antibody titres illustrates that most
infection occurs in infants aged 4–24 months of age
corresponding to the rapid rise in IgG seropositivity
at this time. Significant changes in IgG antibody titres
were observed and reflect age-specific dynamics of
infection. An increase in mean titre during the second
6 months after birth, when most primary infections
occur could simply result from the time required to
develop a full IgG response following infection.
Repeated exposure to infection boosting IgG re-
sponses or an increased immunocompetence with age,
has been suggested for other viral infection, e.g.
respiratory syncytial virus [22]. The decline in titre
thereafter implies reduced exposure to reinfection or
that reinfection does not subsequently affect IgG
antibody responses. Mean titres continue to decline
through adulthood as has been seen for other viral
infections [23, 24] but remain seropositive indicating a
long duration and}or constant re-exposure. The IgG
profile does not reflect the amount of infection that
may be occurring in older age groups after primary
infection which can be seen from the IgM profile.
High IgM levels seen in adults clearly implies a high
re-exposure frequency. Although adults are becoming
reinfected their role in transmission through viral
shedding has not been studied extensively. Adults may
act as an important source of infection and may
contribute to maintenance of virus within communi-
ties [25]. The role of adult transmission in different
epidemiological and socioeconomic settings, as well as
the potential role of animals (livestock) in rural
communities, needs further investigation.
The proportion IgA seropositive, which clearly rose
constantly with age, is less easy to interpret. Low
serum IgA titres within the community may not reflect
its immunological importance during infection nor be
sensitive enough to reflect the dynamics of secretory
IgA in the intestine, likely to be the most important
humoral response in protection, albeit short-lived
[21, 26]. The increase in IgA seroprevalence with age
may simply reflect cumulative exposure to the virus,
or the increase in total IgA known to develop
gradually with age [27], rather than dynamics of
transmission and antibody titre may be more in-
formative in population-based studies.
A lack of association between titres of different
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classes of antibody was perhaps not surprising given
the complex dynamics of humoral responses likely to
exist. With the paired samples, although individuals
appeared to become infected or show evidence of
recent infection (IgM), the numbers were low and
corresponding changes in IgA and IgG may have been
missed within the 1 month period. Several other
factors may influence antibody titre changes, e.g.
infants are likely to be breast fed, the protective effect
of which has caused debate [28] and may influence
development of serum antibody. Additionally, as a
strictly intestinal pathogen, antibody changes in the
serum may not be as sensitive or immediate as those
in the intestine, particularly those due to sub-clinical,
repeated infection. The role of cell-mediated immunity
(CMI) in rotaviral infection has been examined in
animal models [29, 30] and clearly has an important
role, although studies in humans have been limited
[28]. It is not known how CMI may influence the age-
specific dynamics of infection within populations.
This study has not taken into consideration the
extensive genetic diversity of rotaviruses. Recent
molecular epidemiological studies have now shown
that although four serotypes are responsible for the
majority of human disease globally, and it is these
four to which a vaccine is being developed, other
serotypes are not uncommon in many areas [31, 32]
including Sa4 o Paulo [33]. Seroepidemiological studies
which examine age-specific rates of infection with
different serotypes [34, 35] will give more insight into
rates of transmission and interactions between these
four, and other serotypes less prevalent in humans,
especially now that EIA assays, more appropriate for
population-based studies as opposed to plaque neu-
tralization tests, have been developed [12, 36].
The rationale behind immunization programmes
where the focus is on interruption of transmission,
such as for measles and rubella, is to increase
population immunity, by reducing the proportion
susceptible, beyond a threshold which reduces the
effective reproductive rate (R) below one such that
chains of transmission cannot be perpetuated [6].
Those vaccinated or infected are considered immune
for life and play no further role in transmission. This
would not be the case with rotavirus where repeated
infection, and, therefore, transmission occurs in all
age classes. A rotaviral vaccine which neither provides
complete protective immunity nor interrupts trans-
mission will have, as yet, unexplored effects on
patterns of infection and disease, particularly with the
underlying complexity of genetic diversity. Further-
more, heterologous protection in natural disease may
be less marked with vaccine protection. Studies on the
population level effects of interacting rotavirus strains,
each conferring partial cross-immunity accompanied
by relevant immuno-epidemiological studies are re-
quired.
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